IMUX Immunic, Inc.
Healthcare$13.05+6.10%ClosedMarket Cap: $128.8M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
2.60
P/S
0.00
EV/EBITDA
0.52
DCF Value
$0.60
FCF Yield
-63.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-220.7%
ROA
-55.0%
ROIC
-72.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-33.2M | $-32.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-23.3M | $-19.3M | $— | — |
| FY null | $0.00 | NaN% | $-103.2M | $-97.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-26.0M | $-25.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-27.1M | $-26.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-26.8M | $-25.5M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-25.6M | $-25.2M | $— | — |
| FY null | $0.00 | NaN% | $-98.1M | $-100.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-25.7M | $-24.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-22.8M | $-21.4M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-23.9M | $-29.6M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-23.4M | $-21.6M | $-0.48 | — |